NeurAxis Negative Information Hot Off the Press and Regurgitated

Despite positive developments, the same concerns persist to dampen investor sentiment.

NeurAxis (NRXS) is our flagship stock. The company has made great strides over the last year to commercialize its lead product, the IB-Stim device for treating pain associated with severe irritable bowel syndrome (”IBS”) and related conditions.

Please review our previous write-ups on Microcap Opportunities for our bullish thesis. In this article, we’ll s…